The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation

Haemophilia

Volumn 23, Issue 5, 2017, Pages 728-735

  Hay, C R M ^a,b   Xiang, H ^b   Scott, M ^b,c   Collins, P W ^d   Liesner, R ^e   Dolan, G ^f   Hollingsworth, R ^g  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b National Haemophilia Database   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g MDSAS   (United Kingdom)

Author keywords

haemophilia; haemtrack; home therapy; patient reported outcomes

Indexed keywords

ARTICLE; CONTROLLED STUDY; HAEMTRACK HOME THERAPY REPORTING SYSTEM; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PAIN SEVERITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROCESS DESIGN; PROCESS DEVELOPMENT; SOFTWARE; UNITED KINGDOM; ADOLESCENT; ADULT; AGED; BLOOD CLOTTING DISORDER; CHILD; COMPUTER INTERFACE; DISEASE MANAGEMENT; FACTUAL DATABASE; HOME CARE; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROCEDURES; STANDARDS; STATISTICS AND NUMERICAL DATA; TELEMEDICINE; TELEMETRY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS, INHERITED; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DISEASE MANAGEMENT; HOME CARE SERVICES; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; TELEMEDICINE; TELEMETRY; UNITED KINGDOM; USER-COMPUTER INTERFACE; YOUNG ADULT;

EID: 85031920515     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.13287     Document Type: Article

References (15)

1. Collins PW, Bolton-Maggs P, Stephenson D, Jenkins B, Loran C, Winter M. Pilot study of an internet-based electronic patient treatment record and communication system for haemophilia, Advoy.com. Haemophilia. 2003;9:285–291.
2. Mondorf W, Siegmund B, Mahnel R, et al. Haemoassist – a hand-held electronic patient diary for haemophilia home care. Haemophilia. 2009;15:464–472.
3. Valee-Smejda S, Hahn M, Aubin N, Rosmus C. Recording practices and satisfaction of haemophiliac patients using two different data entry systems. Comput Inform Nurs. 2009;27:372–378.
4. Walker I, Sigouin C, Sek J, et al. Haemophilia. 2004;10:698–704.
5. Sholapur NS, Barty R, Wang G, Almonte T, Heddle NM. A survey of patients with haemophilia to understand how they track product used at home. Haemophilia. 2013;19:e289–e295.
6. Calvez T, Chambost H, Claeyssens-Donadel S, et al. Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A. Blood. 2014;124:3398–3408.
7. Valentino L, Walsh CE, Reding MT, Young GA, Levendoglu-Tugai O, Cooper DL. Patient and caregiver reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the dosing observational study in haemophilia (DOSE). Haemophilia. 2012;18:554–560.
8. Young G, Solem CT, Hoffman K, et al. Capturing daily assessments and home treatment of congenital haemophilia with inhibitors: design, disposition and implications of the dosing, observational study in haemophilia (DOSE). J Blood Med. 2012;3:131–138.
9. Scott M, Nummi V, Lassila R, Xiang H, Hay CRM. Weekly Benefix prophylaxis for severe haemophilia B in normal Clinical Practice: data from UKHCDO and Finland. Haemophilia. 2017, https://doi.org/10.1111/hae.13228.
10. Hay CRM, Church N, Choudhri S, Kessler CM; on behaf of the ECHO Steering Committee. Expanding communications on hemophilia A outcomes (echo) study: a longitudinal, observational disease registry of patient-reported and clinical outcomes in patients with hemophilia A. J Thromb Haemost. 2015;13(suppl 2):859.
11. Winding B, Oldenburg J, Hay CRM, et al. Rationale and study design for a prospective, non-interventional phase 4 study evaluating the effectiveness of recombinant factor VIII Fc compared with conventional FVIII concentrates in the prophylactic treatment of haemophilia A: the A-Sure Study. J Thromb Haemost. 2017;1(suppl 1):67.
12. Hay CRM, Palmer BP, Scott M, et al. The thunder study: haemophilia epidemiology, treatment outcomes and unmet needs in the UK: an analysis from the UK National Haemophilia Database. J Thromb Haemost. 2017;23:e240–e243.
13. Hay CRM, Palmer BP, Xiang H. UKHCDO Annual Report 2015 and Bleeding Disorder Statistics for the financial year 2014/15. Copyright UKHCDO 2015.
14. World Federation of Hemophilia Report on the Annual Global Survey 2013. Copyright World Federation of Haemophilia 2014. Thromb Haemostas. 2017;1(suppl 1):678.
15. Berntorp E, Dolan G, Hay CRM, et al. European retrospective study of real-life haemophilia treatment. Haemophilia. 2017;23:105–114.